Can You Have Plastic Surgery with Lupus, Rheumatoid Arthritis or Immunosuppressive Medication?

Written by: Estexper Medical Editorial Team

Medically reviewed by: Mehmet Ozdemir, MD

Having lupus, rheumatoid arthritis or another condition treated with immunosuppressive medication does not automatically rule out plastic or aesthetic surgery. However, elective surgery requires more careful assessment than it may for someone without an autoimmune or connective-tissue disease.

In Short

Plastic surgery may be possible for some people with stable, well-controlled lupus or rheumatoid arthritis. Suitability depends on disease activity, organ involvement, medications, steroid exposure, smoking, clotting risk and the planned procedure. Medication changes and surgical timing should be coordinated by the plastic surgeon, rheumatologist and other relevant clinicians.

The most important question is not simply whether you have lupus or rheumatoid arthritis. Your suitability depends on whether the condition is stable, which organs are affected, what medications you take, your steroid exposure, smoking status, other health conditions and the type of procedure you are considering.

At Estexper Clinic, patients considering treatment in Turkey should provide complete medical information before travelling. A plastic surgeon, rheumatologist, anaesthesiologist and any other relevant specialist may need to coordinate the plan. This helps the medical team balance the risk of infection, delayed healing, blood clots and disease flare against the expected benefits of surgery.

Is plastic surgery possible with lupus or rheumatoid arthritis?

Some people with stable, well-controlled lupus or rheumatoid arthritis can undergo aesthetic surgery. A diagnosis alone is not necessarily a contraindication. Nevertheless, elective surgery may need to be postponed if the disease is active, inflammation is uncontrolled, an infection is present, important organ involvement has not been assessed or another significant health problem is not adequately managed.

Lupus can affect several body systems, so the assessment may include consideration of kidney, heart, lung or blood-related issues. The medical team may also evaluate thrombosis risk, including the possibility of antiphospholipid-antibody-related clotting risk, as well as current steroid and immunosuppressive treatment.

With rheumatoid arthritis, the evaluation may focus on disease activity, current medication, infection risk, mobility and any issues that could affect anaesthesia or recovery. The decision is individual and should be made by a qualified physician who has reviewed your medical history.

What does the research say about aesthetic surgery?

Evidence specifically examining cosmetic surgery in people with connective-tissue diseases remains limited. A 2024 retrospective matched cohort study evaluated 319 patients with connective-tissue diseases, including rheumatoid arthritis and systemic lupus erythematosus, and 319 matched controls who underwent aesthetic surgery.

The study found no significant overall difference in complication rates between the two groups. It also found no significant difference in outcomes for blepharoplasty, breast reduction, abdominoplasty or rhytidectomy. However, breast augmentation was associated with a higher complication rate in the connective-tissue-disease group.

These findings are useful, but they do not mean that every patient with lupus or rheumatoid arthritis has the same level of risk. The study was retrospective and conducted at a single centre, and the evidence for individual cosmetic procedures remains limited. Your medical condition, medications and planned operation may differ substantially from those in the study.

When might elective surgery be delayed?

A surgeon or specialist may recommend postponing an elective procedure when the potential risks are not adequately controlled. Possible reasons include:

  • Active lupus or rheumatoid arthritis with significant inflammation or a recent flare
  • An active infection or a poorly controlled medical condition
  • Important kidney, heart, lung or blood-related involvement requiring further assessment
  • High or prolonged corticosteroid exposure that cannot yet be safely reviewed
  • Medication combinations that substantially increase infection or wound-healing concerns
  • Ongoing smoking or other factors that may impair recovery
  • Significant thrombosis risk that has not been assessed or managed
  • Insufficient time to arrange safe postoperative monitoring, particularly for international patients

Postponement is not necessarily a permanent refusal. It may allow time to improve disease control, complete specialist investigations, adjust medications safely or arrange a more suitable recovery plan.

How do immunosuppressive medications affect surgery?

Immunosuppressive medication can reduce autoimmune inflammation, but it may also affect the body’s ability to respond to infection or heal after an operation. The correct perioperative plan depends on the exact medicine, dose, half-life, treatment schedule, disease severity and procedure.

There is no universal rule that all immunosuppressive medication must be stopped before plastic surgery. In some cases, conventional disease-modifying antirheumatic drugs are continued. Biologic medicines, targeted therapies and other immunosuppressants may be timed or temporarily withheld, depending on the individual circumstances.

Medication decisions must balance two risks: postoperative infection and impaired healing if treatment continues, versus an autoimmune flare if treatment is interrupted. The 2022 American College of Rheumatology and American Association of Hip and Knee Surgeons guideline for elective hip and knee replacement generally recommends continuing several conventional disease-modifying medicines, withholding some biologic therapies for one dosing interval and restarting withheld treatment after adequate wound healing and no infection. These principles are informative, but the guideline was developed for joint-replacement surgery, not cosmetic surgery. Your plastic surgeon and rheumatologist should adapt the plan to your operation.

Never stop a biologic, disease-modifying medicine or other immunosuppressive treatment on your own. Interrupting treatment without medical advice can lead to a flare or other complications.

What about corticosteroids?

Glucocorticoids, such as prednisone-based treatment, deserve particular attention. Chronic or higher-dose steroid exposure is associated with increased postoperative infection and other complications. Before elective surgery, your specialists may assess whether the dose can be reduced safely while maintaining disease control.

However, steroids should not be stopped suddenly. Abrupt discontinuation can be unsafe, and any perioperative steroid plan should be decided by the clinicians managing your care.

What should happen before plastic surgery?

A thorough consultation is essential. Bring an up-to-date list of every prescription medicine, injection, over-the-counter medicine and supplement you use. Include the dose, frequency, most recent administration date and the reason for treatment. Your team should also know about previous operations, allergies, infections, blood-clotting problems and any past anaesthetic difficulties.

Your rheumatologist may need to provide information about disease activity, recent flares, organ involvement and the safety of changing medication. Depending on your history, the team may request laboratory tests or specialist reviews. The exact tests cannot be determined without an individual assessment.

Tell the clinic if you smoke or use nicotine. Smoking can create additional concerns for circulation, wound healing and infection, and your surgeon may advise you about stopping before surgery. You should also report recent fever, skin infection, respiratory illness, unexplained symptoms or changes in your autoimmune disease.

Planning treatment in Turkey

International patients should complete the medical assessment before booking flights. Send accurate medical records, medication details and relevant specialist letters for review. If the surgeon believes that an in-person assessment or further specialist opinion is needed, this should be arranged before the operation.

Ask who will manage your care after surgery, how follow-up will be provided and what will happen if you develop a fever, wound problem or possible autoimmune flare after returning home. Your travel schedule should allow appropriate postoperative review rather than requiring an early departure. It is also important to understand that a remote review cannot replace an examination when symptoms are concerning.

Does the type of procedure matter?

Yes. The extent and location of surgery influence the recovery plan and the possible consequences of infection or delayed wound healing. The 2024 matched cohort study did not find significantly different complication rates for several procedures, including eyelid surgery, breast reduction, abdominoplasty and facelift surgery, but it did identify a higher complication rate for breast augmentation among patients with connective-tissue diseases.

This result should be interpreted carefully. It does not prove that breast augmentation is unsuitable for every patient with lupus or rheumatoid arthritis, nor does it predict an individual outcome. It does show why the proposed procedure, implant or technique, disease status and medication plan should be discussed specifically rather than relying only on the diagnosis.

A surgeon may also consider whether a less extensive option could address your goals with fewer medical demands. The appropriate choice depends on your anatomy, expectations and health assessment.

What are the possible risks?

Patients with autoimmune disease or immunosuppressive treatment may have additional concerns, although the level of risk varies widely. These may include:

  • Postoperative infection
  • Delayed wound healing or wound separation
  • Autoimmune disease flare
  • Blood clots, particularly when individual thrombosis risk is elevated
  • Medication-related complications
  • Problems related to anaesthesia or underlying organ involvement
  • Need for additional treatment or closer follow-up if a complication occurs

These are possibilities, not predictions. A well-controlled condition does not eliminate risk, and an autoimmune diagnosis does not guarantee that complications will occur. The purpose of preoperative planning is to identify modifiable risks and decide whether the expected benefits justify proceeding.

Recovery and aftercare

Follow your surgeon’s wound-care and activity instructions carefully. Attend all planned reviews and keep your rheumatologist informed about any medication changes. Do not restart a withheld medicine or change a steroid dose unless the responsible doctors have agreed that it is appropriate.

Contact your medical team promptly if you develop increasing redness, swelling, drainage, wound opening, fever, breathing difficulty, chest pain, unusual limb swelling or symptoms that feel like a significant autoimmune flare. International patients should receive written instructions and a clear emergency contact pathway before leaving the clinic.

Aftercare may require coordination between the Turkish surgical team and your local doctors. Share the operative report, discharge information and medication plan with your rheumatologist or primary physician. This is especially important if treatment was paused or if you need assessment after returning home.

Questions to ask your surgical and rheumatology teams

  • Is my lupus or rheumatoid arthritis sufficiently stable for elective surgery?
  • Does any organ involvement change the anaesthetic or surgical risk?
  • Which medicines should continue, and which may need timing or temporary interruption?
  • How will we reduce the risk of infection, delayed healing or a disease flare?
  • Do I have additional thrombosis risk that requires assessment?
  • How long should I remain available for follow-up in Turkey?
  • Who should I contact if symptoms develop after I return home?

Key takeaway

Plastic surgery may be possible with lupus, rheumatoid arthritis or immunosuppressive medication, but suitability cannot be decided from the diagnosis alone. Stable disease, careful medication planning, assessment of organ and clotting risks, appropriate procedure selection and coordinated follow-up are central to safer decision-making.

Because cosmetic-surgery evidence in autoimmune disease is still limited, every case should be assessed individually by a qualified plastic surgeon together with the patient’s rheumatologist and other relevant specialists. Do not stop steroids or immunosuppressive medication without medical direction, and make sure your health information is reviewed before travelling to Turkey.

Explore our Plastic Surgery services in Turkey for an overview of treatment options and individual assessment.

TREATMENT OPTIONS

Explore Your Treatment Options

Find out more about our services and discuss which options may suit your individual needs.

YOUR NEXT STEP

Discuss Your Questions With Our Team

Request an individual assessment or ask our team about treatment planning and follow-up arrangements.

Medical References

We will be happy to hear your thoughts

      Leave a reply

      Estexper Clinic
      Logo
      Shopping cart